NeoPharm Co

NeoPharm Co EBIT per Share

The EBIT per Share of NeoPharm Co (092730.KQ) as of Oct 14, 2026 is 1,839.66 KRW. In the previous year, EBIT per Share was 1,575.97 KRW — a change of 16.73% (higher).

EBIT per Share

1,839.66KRW

YoY

16.73%

Last updated:

EBIT per Share of NeoPharm Co is 2025 1,839.66 KRW. EBIT per Share of NeoPharm Co was 2024 1,575.97 KRW. It decreases by 16.73% higher compared to the previous year.

The NeoPharm Co EBIT per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT per Share
Date
EBIT per Share
Jan 1, 2021
2,866.75 KRW
Jan 1, 2022
2,740.52 KRW
Jan 1, 2023
3,234.25 KRW
Jan 1, 2024
1,575.97 KRW
Jan 1, 2025
1,839.66 KRW
Jan 1, 2026 (e)
2,585.57 KRW
Jan 1, 2027 (e)
3,335.05 KRW
Jan 1, 2028 (e)
3,933.10 KRW
The NeoPharm Co EBIT per Share history
YEAREBIT per ShareYoY
est3,933.10KRW+17.93%
est3,335.05KRW+28.99%
est2,585.57KRW+40.55%
1,839.66KRW+16.73%
1,575.97KRW-51.27%
3,234.25KRW+18.02%
2,740.52KRW-4.40%
2,866.75KRW+2.36%
2,800.55KRW-3.41%
2,899.48KRW+8.07%
2,683.04KRW+40.68%
1,907.25KRW+41.11%
1,351.64KRW+108.15%
649.37KRW-9.14%
714.71KRW+132.91%
306.86KRW-1,862.47%
-17.41KRW-109.99%
174.29KRW+45.07%
120.14KRW-57.09%
280.00KRW-43.87%
498.86KRW+55.89%
320.00KRW-43.91%
570.50KRW—
Access this data via the Eulerpool API
Get Free API Key

NeoPharm Co Stock analysis

What does NeoPharm Co do? NeoPharm Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about NeoPharm Co stock

EBIT per Share of NeoPharm Co is 1,839.66 KRW in 2025.

EBIT per Share of NeoPharm Co changed from 1,575.97 KRW to 1,839.66 KRW, representing a 16.73% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EBIT per Share NeoPharm Co since 2006 – with annual values, charts, and detailed analysis.

EBIT per Share measures operating profit allocated to each outstanding share.

Access this data via the Eulerpool API
Get Free API Key

Income Statement — NeoPharm Co

RevenueGross ProfitEBITEBITDANet IncomeEPSCost of Goods SoldR&D ExpensesSG&A ExpensesOperating ExpensesInterest ExpensePretax IncomeTax ExpenseDepreciation & AmortizationRevenue per ShareEBIT per ShareDiluted EPSEBITDA per ShareOther Income/Expense

All Key Metrics — NeoPharm Co